Ambitious academic AI institution opens in Paris

A European university with deep historic roots is now home to an AI research center whose areas of concentration include healthcare.

Sorbonne University announced the opening of the Sorbonne Center for Artificial Intelligence (SCAI) in Paris earlier this week.

The facility is set to host 100 scientists and 150 doctoral and post-doctoral researchers. And its initial headcount of around 300 students will include those attending a satellite center in the United Arab Emirates.

On Wednesday, the university, an offshoot of the Collège de Sorbonne founded in the 13th century, ran a quick Q&A with the inaugural director of SCAI (which is not to be confused with the U.S.-based organization using the same acronym, the Society for Cardiovascular Angiography and Interventions).

“Artificial intelligence raises more or less scientifically based concerns,” says the director, Gérard Biau, a Sorbonne professor of probability, statistics and modeling. “By mobilizing the critical spirit and the scientific approach, the human and social sciences will be able to help us to better analyze the relations that we have with these digital upheavals and their impacts on our existence.”

Along with healthcare, the new SCAI will concentrate on AI fundamentals and applications in mathematics, informatics, robotics, climate and environment, as well as on humanities issues that may be addressable by algorithms.  

Read the rest:

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.